Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Podcasts & Videos
上一篇:‘Most... anihC ni ti od ew woh si sihT
下一篇:Pepe... wohS ogacihC soseuH soL atsaH